QuickView for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=8CAE4D2F6D2ADAA7000690C3A4BABDF2;jsessionid=59527D2BB9ADB40D0FF86D690D2CAA77;jsessionid=4611458D3173AC9A7FB1296B151D0C12;jsessionid=636E97E918E33141C83BCCD0DC6CB41A;jsessionid=6E1162D504A4D2567209538C93A955A5;jsessionid=97D7BD75032D63AF42EF3B9832A37F01;jsessionid=DC7C1993DD17145956810D63D8EFD80A;jsessionid=093584CAE3BDA65A6CB8C08AB53EF28B;jsessionid=E4BEC11A2AA53A0F15C0107A328FC7C8;jsessionid=6FB728CD9278023F2FAD2C35A9EAD371 (gene)

1. AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistan…
2. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Mat…
3. A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.
4. Cooperative Nucleotide Binding in Hsp90 and Its Regulation by Aha1.
5. A Split Renilla Luciferase Complementation Assay for the Evaluation of Hsp90/Aha1 Complex Disruptors…

There were no clinical trials for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=8CAE4D2F6D2ADAA7000690C3A4BABDF2;jsessionid=59527D2BB9ADB40D0FF86D690D2CAA77;jsessionid=4611458D3173AC9A7FB1296B151D0C12;jsessionid=636E97E918E33141C83BCCD0DC6CB41A;jsessionid=6E1162D504A4D2567209538C93A955A5;jsessionid=97D7BD75032D63AF42EF3B9832A37F01;jsessionid=DC7C1993DD17145956810D63D8EFD80A;jsessionid=093584CAE3BDA65A6CB8C08AB53EF28B;jsessionid=E4BEC11A2AA53A0F15C0107A328FC7C8;jsessionid=6FB728CD9278023F2FAD2C35A9EAD371